October 4, 2022

ListOfAnime

How to watch Anime Online and get the latest news

Rising of Shield Hero's Lead Voice Actor Reveals Stage IV Cancer Diagnosis

Voice Actor Billy Kametz


Rising of Protect Hero’s Lead Voice Actor Reveals Stage IV Most cancers Prognosis

Jojo’s Weird Journey and Rising of the Protect Hero actor Billy Kametz broadcasts he takes a break from performing to deal with his well being.

Billy Kametz, the English voice of The Rising of the Protect Hero‘s central protagonist Naofumi, broadcasts he takes a break from performing following a most cancers analysis.

He additionally revealed that he might be taking a break from performing and might be transferring again in together with his household in the interim. “There are some exhibits that I used to be doing that I wasn’t capable of end… [Rising of the Shield Hero] is coming again for a Season 2 and a Season 3 and I am sadly not going to be part of it,” he said. Whereas his roles must be recast, Kametz inspired his followers to assist his replacements. “It is such a bizarre factor for an actor to must do… If you happen to might simply assist the crap out of them, simply be their greatest cheerleader, that may make me actually, actually completely satisfied.”

In accordance with the actor, the most cancers has unfold to his liver, lungs and backbone. “My nerves have been shut off on my left arm for fairly a while, so I’ve like zero power, so video video games are out of the query for proper now, which sucks” mentioned Kametz, who often posts on social media in regards to the video video games he’s taking part in. Regardless of the analysis, Kametz is optimistic that he’ll overcome the sickness. “I am going to simply kick this factor’s butt after which we’ll be again,” he mentioned. “I am not going to stop. I am very optimistic, I am very hopeful. If you happen to pray, I’ll take it. If you happen to’re an vitality individual, I am going to take any good vibes… Let’s simply hivemind this factor proper out of me,” the actor mentioned with a smile.